Phil

Medication Access, Simplified.

San Francisco, United States · Founded 2015 · $91.0M raised

Employees
51–200
Founded
2015
Business Model
B2B
Website
phil.us
Total Funding
$91.0M
Last Round
$56.0M Series DJun 2021
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 11 investors for this company. The full record is or through the API.

About

Software therapy deployment platform simplifying prescription management, delivery, and patient access for pharmaceutical manufacturers and patients. PHIL's digital hub solves medication access and GTN challenges for retail and specialty-lite brands, maximizing patient enrollment, prior authorizations, covered dispenses, and adherence through integrated pharmacy networks and end-to-end visibility.

Summary

Phil is a Drug Discovery company based in San Francisco, United States, founded in 2015. It has raised $91.0M in total across 4 rounds, most recently a $56.0M Series D round in Jun 2021. Investors include Crosslink Capital, K2 HealthVentures and Warburg Pincus.

Tech & App Stack

9 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Debt FinancingDebt FinancingJul 2025
$60.0M

Sign up to see all 5 events

Funding: Seed through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Shields Health Solutions

The nation's first company to integrate specialty pharmacies into hospitals and health systems, h...

United StatesHealthcare, Drug Discovery
Corporate RoundTotal funding$3.5BSep 2025
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Phil on Indexed.vc
<a href="https://indexed.vc/companies/phil"><img src="https://indexed.vc/api/badge/company/phil" alt="Phil on Indexed.vc" width="260" height="76" /></a>